Zebra Technologies Enters Into Revolving Credit Agreement to Support Comp...(s can be found at http:// CONTACT: ....)
Navigation Links
Zebra Technologies Enters Into Revolving Credit Agreement to Support Company Growth
Date:8/15/2008
s can be found at http://www.zebra.com.
CONTACT:
Investors: Financial Media:
Douglas A. Fox, CFA Tim Dreyer
VP, Investor Relations Manager, Public Relations
+1 847 793 6735 +1 847 793 5677
dfox@zebra.com tdreyer@zebra.com
'/>"/>
| SOURCE Zebra Technologies Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology news :
1. Deadly genetic disease prevented before birth in zebrafish
2. A screening strategy using zebrafish targets genes that protect against hearing loss
3. New map outlines risk of zebra mussel invasion
4. New national map shows relative risk for zebra and quagga mussel invasion
5. Study shows how the zebrafish gets his stripe
6. Zebrafish to shed light on human mitochondrial diseases
7. Integrated Fuel Technologies gets worldwide license for Argonne-developed Diesel DeNOx Catalyst
8. Pitt faculty receive awards to explore next-generation technologies
9. OSU technologies funded for development
10. CrimeCog Technologies Unveils Enhanced JMS Module of E*JUSTICE SYSTEMS(TM)
11. Oberthur Technologies XPon Offer
Post Your Comments:
Breaking Biology News(10 mins):Uniform analyses for clean drinking water in Europe 2Abundance of a look-alike species clouds population status of a million dollar fish 2Abundance of a look-alike species clouds population status of a million dollar fish 3UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students 2Procter 26 Gamble Announces Appointment of Director 54371 1Procter 26 Gamble Announces Appointment of Director 54371 2ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results 13533 1ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results 13533 2ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results 13533 3ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results 13533 4ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results 13533 5ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results 13533 6ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results 13533 7Scientists demonstrate importance of niche differences in biodiversity 9554 1Scientists demonstrate importance of niche differences in biodiversity 9554 2
Other Biology News:First-ever study to link increased mortality specifically to carbon dioxide emissions 2First-ever study to link increased mortality specifically to carbon dioxide emissions 3First-ever study to link increased mortality specifically to carbon dioxide emissions 4First-ever study to link increased mortality specifically to carbon dioxide emissions 5
Breaking Biology Technology:Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3Dendreon Appoints Hans Bishop as Chief Operating Officer 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3
Other Biology Technology:Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 2Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 3Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 4Researchers develop new model for cystic fibrosis 2Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 2Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 3Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 4Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |